首页>
外国专利>
antitumor agent employing compounds which, in combination, have kinase inhibiting effect.
antitumor agent employing compounds which, in combination, have kinase inhibiting effect.
展开▼
机译:组合使用具有激酶抑制作用的化合物作为抗肿瘤剂。
展开▼
页面导航
摘要
著录项
相似文献
摘要
An anti-tumor agent employing compounds which, in combination, have a kinase inhibiting effect. An anti-tumor agent employing a compound represented by the formula (I) or a pharmaceutically acceptable salt thereof, in combination with a compound represented by the formula (ii), is disclosed; a pharmaceutically acceptable salt thereof. The antitumor agent exhibits a surprising antitumor effect compared to cases where each of the above compounds is used individually. In addition, the antitumor agent exhibits antitumor effect against various cancers. (in the formulas, R ^ 1 ^ represents an azetidinyl group or the like; R ^ 2 ^ ar ^ 5 ^ each represents a hydrogen atom or a halogen atom; R ^ 6 ^ represents a C 3-3 cycloalkyl group 8 ~ or similar; R 7 represents a hydrogen atom or the like; and r 8 represents a halogen atom or the like.
展开▼
机译:使用组合具有激酶抑制作用的化合物的抗肿瘤剂。公开了使用式(I)代表的化合物或其药学上可接受的盐与式(ii)代表的化合物结合的抗肿瘤剂;其药学上可接受的盐。与上述每种化合物单独使用的情况相比,该抗肿瘤剂表现出令人惊讶的抗肿瘤作用。另外,该抗肿瘤剂显示出对各种癌症的抗肿瘤作用。 (式中,R ^ 1 ^表示氮杂环丁烷基等; R ^ 2 ^ ar ^ 5 ^分别表示氢原子或卤素原子; R ^ 6 ^表示C 3-3环烷基8〜或R 7表示氢原子等; r 8表示卤素原子等。
展开▼